Status:
COMPLETED
Academic-Community EPINET (AC-EPINET)
Lead Sponsor:
Indiana University
Collaborating Sponsors:
University of Michigan
Ohio State University
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
16-35 years
Phase:
NA
Brief Summary
The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month, randomized tria...
Detailed Description
160 subjects will be randomized into a 12 month study, to one of two treatment arms. The investigators will assess four important elements of engagement to determine which are most sensitive to TH tre...
Eligibility Criteria
Inclusion
- Between 16 and 35 years of age
- Able to give informed consent
- Willing and able to adhere to the study schedule
- New intakes enrolled in one of the six clinical programs
- Non-affective (schizophrenia, schizoaffective, schizophreniform) and affective (major depression with psychotic features, bipolar disorder with psychotic features) psychotic disorders with onsets within 5 years of enrollment.
Exclusion
- 1\. Known IQ \< 70 based on participant report
Key Trial Info
Start Date :
March 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2025
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04497857
Start Date
March 16 2022
End Date
July 29 2025
Last Update
December 24 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Prevention and Recovery Center for Early Psychosis
Indianapolis, Indiana, United States, 46202
2
Early Psychosis Intervention Clinic-New Orleans (EPIC-NOLA) - Tulane University
New Orleans, Louisiana, United States, 70119
3
Program for Risk Evaluation and Prevention (PREP) - University of Michigan
Ann Arbor, Michigan, United States, 48109
4
Strong Ties Young Adults Program- University of Rochester Medical Center
Rochester, New York, United States, 14623